CYPROHEPTADINE HYDROCHLORIDE

CYPROHEPTADINE HYDROCHLORIDE Basic information
Product Name:CYPROHEPTADINE HYDROCHLORIDE
Synonyms:CYPROHEPTADINE HYDROCHLORIDE(GRP B SL NO.1124);1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidinehydrochloride;4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidinehydrochloride;4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-piperidinhydrochloride;cyproheptadienehydrochloride;nuran;CyproheptadineHclCyproheptadineHclBp;CYPROHEPTADINEHYDROCHLORIDE(ANHYDROUS)
CAS:969-33-5
MF:C21H22ClN
MW:323.86
EINECS:213-535-1
Product Categories:Serotonin receptor;Active Pharmaceutical Ingredients
Mol File:969-33-5.mol
CYPROHEPTADINE HYDROCHLORIDE Structure
CYPROHEPTADINE HYDROCHLORIDE Chemical Properties
Melting point 254-256.5 °C(Solv: ethanol (64-17-5); ethyl ether (60-29-7))
storage temp. Inert atmosphere,Room Temperature
solubility ethanol: soluble
form solid
color Crystals from EtOH/Et2O
Water Solubility Soluble in water (15mM)
Stability:Hygroscopic
Safety Information
Hazard Codes Xn
Risk Statements 22-36/37/38
Safety Statements 26-36
RIDADR UN 2811 6.1/PG 3
WGK Germany 3
RTECS TM7050000
HazardClass 6.1(b)
PackingGroup III
ToxicityLD50 orl-rat: 295 mg/kg DRUGAY 6,340,82
MSDS Information
ProviderLanguage
SigmaAldrich English
CYPROHEPTADINE HYDROCHLORIDE Usage And Synthesis
OriginatorPeriactin,Merck Sharp and Dohme,US,1961
UsesAntipruritic;5-HT antagonist
UsesCyproheptadine hydrochloride is an antihistamine in which antiserotonin activity has been demonstrated both in vivo and in vitro. As yet, however, there is no evidence that this action contributes to clinical therapeutic effects. Anticholinergic and sedative effects are observed. Cyproheptadine may be more effective than other H1 blockers in the management of cold urticaria.
DefinitionChEBI: The hydrochloride salt of cyproheptadine. Note that the drug named cyproheptadine hydrochloride generally refers to cyproheptadine hydrochloride sesquihydrate.
Manufacturing Process(A) Preparation of 1-Methyl-4-Piperidyl-Magnesium Chloride: Magnesium turnings (5.45 g, 0.22 g-atom) were placed in a 500 ml 3-necked flask provided with a condenser, Hershberg stirrer and dropping funnel and protected with a drying tube. An atmosphere of dry nitrogen was maintained in the apparatus throughout the reaction. The magnesium was covered with 20 ml of dry tetrahydrofuran. A crystal of iodine and 1.2 g of ethyl bromide were added and after the reaction had subsided (formation of ethylmagnesium bromide) a solution of 29.4 g (0.22 mol) of 4-chloro-1-methyl-piperidine in dry tetrahydrofuran (total volume, 103 ml) was added dropwise at such a rate that gentle reflux was maintained.
The solution of 4-chloro-1-methylpiperidine in tetrahydrofuran was dried over calcium hydride at ice-bath temperature prior to use. When the addition of the halide was complete the reaction mixture was refluxed with stirring for one hour. In some subsequent experiments this period of refluxing was omitted with no deleterious result.
The solution of 4-chloro-1-methylpiperidine in tetrahydrofuran was dried over calcium hydride at ice-bath temperature prior to use. When the addition of the halide was complete the reaction mixture was refluxed with stirring for one hour. In some subsequent experiments this period of refluxing was omitted with no deleterious result.
The solvent was evaporated from the combined benzene extracts to give 33.4 g of a clear light brown resin. Crystallization from an alcohol-water mixture gave 19.5 g of 1-methyl-4-(5-hydroxy-5-dibenzo[a,e]cycloheptatrienyl)- piperidine, MP 156° to 157°C. Two recrystallizations from alcohol-water mixtures followed by two recrystallizations from benzene-hexane mixtures gave analytically pure product, MP 166.7° to 167.7°C.
(C) Preparation of 1-Methyl-4-(5-Dibenzo[a,e]Cycloheptatrienylidene)- Piperidine Hydrochloride: 1-Methyl-4-(5-hydroxy-5-dibenzo[a,e] cycloheptatrienyl)-piperidine (3.05 g, 0.01 mol) was dissolved in glacial acetic acid, 15 ml. The solution was saturated with dry hydrogen chloride with external cooling. A white solid separated. Acetic anhydride (3.07 g, 0.03 mol) was added and the mixture heated on the steam bath for one hour. The solid dissolved in the first 5 minutes of the heating period.
The reaction mixture was poured into 25 ml of water and the mixture made strongly basic with 10N sodium hydroxide solution. The mixture was extracted 3 times with 50 ml portions of benzene, the combined extracts washed with water and concentrated to a volume of approximately 50 ml. The solution was saturated with dry hydrogen chloride and the white crystalline product collected and dried. The yield of product, MP 251.6° to 252.6°C (dec.) was 2.5 g. Recrystallization from a mixture of absolute alcohol and absolute ether gave a product, MP 252.6° to 253.6°C. A sample was analyzed after drying for 7 hours at 110°C over phosphorus pentoxide in vacuo.
(D) Preparation of 1-Methyl-4-(5-Dibenzo[a,e]Cycloheptatrienylidene)- Piperidine: The hydrochloride salt, 4.3 g, was suspended in 100 ml of warm water and the mixture made strongly alkaline by the addition of 15 ml of 5% sodium hydroxide. The mixture was extracted with four 50 ml portions of benzene and the extracts dried over sodium sulfate. Evaporation of the benzene on the steam-bath at reduced pressure left 3.7 g (97%) of the base,MP 110.3° to 111.3°C. Recrystallization from a mixture of alcohol and water gave product, MP 112.3° to 113.3°C.





Brand namePeriactin (Merck).
Therapeutic FunctionAntipruritic, Antihistaminic, Appetite stimulant
General DescriptionCyproheptadinehydrochloride, 4-(5H-dibenzo-[a,d]-cyclohepten-5-ylidine)-1-methylpiperidine hydrochloride sesquihydrate(Periactin), is slightly soluble in water and sparingly solublein alcohol.
Cyproheptadine possesses both antihistamine and antiserotoninactivity and is used as an antipruritic agent. It isindicated for the treatment of hypersensitivity reactions,perennial, and seasonal allergic rhinitis; vasomotor rhinitis;allergic conjunctivitis, uncomplicated allergic skin manifestationsof urticaria and angioedema; amelioration of allergicreactions to blood or plasma; and cold urticaria. It is alsoused off-label for nightmares associated with posttraumaticstress disorder (PTSD), prevention of migraine, suppressionof vascular headaches, and appetite stimulation. Sedation isthe most prominent side effect, and this is usually brief, disappearingafter 3 or 4 days of treatment.
Biological ActivityNon-selective 5HT 2 antagonist, migraine prophylactic.
Safety ProfilePoison by ingestion and intraperitoneal routes. Human systemic effects by ingestion: jaundice, liver function tests impaired, gastrointestinal effects. An experimental teratogen. Experimental reproductive effects. Human mutation data reported. Whenheated
Drug interactionsPotentially hazardous interactions with other drugs
Analgesics: sedative properties increased with opioid analgesics.
MetabolismUndergoes almost complete metabolism in the liver. The main metabolite found in humans is a quaternary ammonium glucuronide conjugate of cyproheptadine. 40% is excreted in the urine mainly as metabolites and 2-20% via the faeces.
storageRoom temperature
references[1] levine b, green-johnson d, hogan s, smialek je. a cyproheptadine fatality. j anal toxicol. 1998 jan-feb;22(1):72-4.
[2] lin oa, karim za, vemana hp, espinosa ev, khasawneh ft. the antidepressant 5-ht2a receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function. plos one. 2014 jan 23;9(1):e87026.
CYPROHEPTADINE HYDROCHLORIDE Preparation Products And Raw materials
Raw materialsAcetic anhydride-->Hydrochloric acid-->Magnesium-->Sodium hydroxide-->4-Chloropiperidine hydrochloride-->Bromoethane-->5-(1-Methyl-4-Piperidyl)5H-Dibenzo
Eperisone hydrochloride Rizatriptan benzoate Propranolol hydrochloride Fluoxetine hydrochloride Ketotifen fumarate Sertraline hydrochloride Butenafine hydrochloride Loperamide hydrochloride Cyproheptadine

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.